切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - eIF4E/eIF3G interaction - 5-HT Transporters - O6-methylguanine-DNA-methyl-transferase (MGMT) - Insulin and Insulin-like Receptors

10 件产品

每页
清除全部
  1. 4EGI-1
    B3696 4EGI-1
     2 Citation
    Target: eIF4E/eIF3G interaction
    Summary: 竞争性的eIF4E/eIF4G相互作用抑制剂。
      ≥22.56 mg/mL
  2. Paroxetine HCl
    B2252 Paroxetine HCl
     1 Citation
    中文名: 盐酸帕罗西汀
    Target: 5-HT Transporters
    Summary: 抗抑郁药
      ≥36.73 mg/mL
      insoluble in H2O
  3. Desvenlafaxine
    B2236 Desvenlafaxine
    中文名: 去甲文拉法辛
    Target: 5-HT Transporters|Norepinephrine transporters
    Summary: 5-羟色胺(5-HT)和去甲肾上腺素(NE)再摄取抑制剂
      ≥13.2 mg/mL
  4. Amitriptyline HCl
    B2231 Amitriptyline HCl
    中文名: 盐酸阿米替林
    Target: Trk Receptors|5-HT2 Receptors|Norepinephrine transporter|5-HT Transporters
    Summary: 血清素/去甲肾上腺素受体/5-HT4/5-HT2抑制剂
      ≥15.69 mg/mL
      ≥43.9 mg/mL
  5. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  6. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  7. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  8. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: 胰高血糖素受体/ IGF-1R拮抗剂
      ≥24.05 mg/mL
      insoluble in H2O
  9. Rosiglitazone maleate
    A4302 Rosiglitazone maleate
    中文名: 马来酸罗格列酮
    Target: Insulin and Insulin-like Receptors
    Summary: PPARγ激动剂,有效的胰岛素敏化剂
      ≥23.7 mg/mL
      insoluble in H2O
  10. Lomeguatrib
    A1912 Lomeguatrib
    中文名: 罗米鲁曲
    Target: O6-methylguanine-DNA-methyl-transferase (MGMT)
    Summary: MGMT抑制剂
      ≥50 mg/mL
      insoluble in H2O

10 件产品

每页